Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.
about
Prognostic value of procalcitonin in pneumonia: A systematic review and meta-analysisBiomarkers in community-acquired pneumonia: a state-of-the-art reviewProcalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis.Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteriaSerum C-reactive protein and procalcitonin kinetics in patients undergoing elective total hip arthroplasty.Elevated plasma stromal-cell-derived factor-1 protein levels correlate with severity in patients with community-acquired pneumonia.Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational studyUsefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical courseUseulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine.Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin.Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience.Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients.The role of procalcitonin in respiratory infections.Biomarkers in community-acquired pneumonia.Emerging infection and sepsis biomarkers: will they change current therapies?Prognostic value of on admission arterial PCO2 in hospitalized patients with community-acquired pneumonia.Serial inflammatory biomarkers of the severity, course and outcome of late onset acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new-onset fever.Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis.Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis.Polymorphism rs2239185 in vitamin D receptor gene is associated with severe community-acquired pneumonia of children in Chinese Han population: a case-control study.Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community-acquired pneumonia.Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.Prognostic scores and biomarkers for pediatric community-acquired pneumonia: how far have we come?Decisional procalcitonin thresholds are not adapted to elderly patients admitted to the emergency room.Value of procalcitonin for diagnosing perioperative pneumonia, urinary infections and superficial surgical site infections in patients undergoing primary hip and knee arthroplasty.
P2860
Q26776356-A49966AA-E735-48C0-ABE3-70F41BE15C42Q27026995-2881AD0A-97BB-4A32-8643-587E9500CF97Q30360003-7683D3C2-7340-4E9F-ABFB-A09C15BC9410Q33325779-443EBC0D-7499-4B7D-BD84-1E4852DB78C1Q33634769-1E501127-08EB-4DF3-8F12-D5EEB9BFDFD8Q34413190-EDE4B199-484A-4449-B207-E915ECB99694Q35559416-498D277F-5C36-454B-9724-791F1275B6F1Q36392655-C4083884-D402-4068-A933-B48700683C35Q37207285-917042BB-F6ED-45F5-BE08-49E4E8D80B6DQ37270551-54A1085F-F2DC-452A-857D-DD96EC49A701Q37318175-9D0DF2A2-CCDD-4F1D-A0F8-761D839686EFQ37347840-29E7B96F-F1E1-4C28-B9C2-6080AAF895BEQ37404766-DE683C14-54E0-40CF-8093-5679EF80E945Q37989831-60830A5B-3EC2-47D5-8AB4-207CFF95DDA2Q37997820-70A991A9-FE21-406E-B49C-2D731A8ED4B4Q38929971-A7F97C7A-1220-4518-88D9-0E5063175DE2Q39170072-17F8EA2E-F1D9-4FFA-A8BC-BC180A796995Q40151360-262FF051-4472-498B-B709-31990EDBC89EQ40281751-C457658E-76DC-443A-82ED-A93111C826FBQ41621139-5D91E555-64D0-4196-8EF5-64AF72FAA59BQ41678972-75920A47-C806-42F4-A890-A023051CACEFQ42055968-8644E658-1FCF-4726-B4A1-2BCED51022F1Q44080564-2E162754-DBE0-4536-A6CA-CEC55A1E84F5Q44504198-3D2C434B-C94A-4429-BE6C-51AA66411DFCQ47641206-8AD4BA93-DBCE-4035-BF5B-8C6016B18D39Q51338932-A73E521D-8228-499C-A433-2D595818FFD0Q55351954-11B486D1-E66C-46E7-BE89-F7978FDB05B2
P2860
Diagnostic and prognostic values of admission procalcitonin levels in community-acquired pneumonia in an intensive care unit.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@en
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@nl
type
label
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@en
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@nl
prefLabel
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@en
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@nl
P2093
P1433
P1476
Diagnostic and prognostic valu ...... nia in an intensive care unit.
@en
P2093
N Boussekey
T d'Escrivan
P2888
P304
P356
10.1007/S15010-005-4096-2
P577
2005-08-01T00:00:00Z